Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-

Details Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2- Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-

1993-09-17

1995-01-10

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514561, 514563, 344236, 344224, 344238, 344239, 568308, A61K 31195, A61K 31495, C07D48704

Patent

active

053807596

ABSTRACT:
Methyl N-[6-(3,4,5-trimethoxybenzloxy) imidazo [1,2-6]pyridazin-2-yl]carbamate is disclosed which is used to treat leukemia.

REFERENCES:
patent: 5091531 (1992-02-01), Hodgson

Affiliated with

Also associated with

Rating

Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2- will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-850983